Valeant Pharmaceuticals
400 Somerset Corporate Blvd.,
Bridgewater, 8807, NJ,
United States
Bridgewater, 8807, NJ,
United States
1 908-927-1400
Manufacturing
Valeant Pharmaceuticals Technographics
Valeant Pharmaceuticals Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Valeant Pharmaceuticals and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 19600 Valeant Pharmaceuticals employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Valeant Pharmaceuticals has purchased the following applications: Oracle NetSuite ERP for ERP Financial in 2012, Microsoft BI (SSRS, SSAS, SSIS, SQL Server Reporting) for Analytics and BI in 2012, Microsoft 365 for Collaboration in 2015 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Valeant Pharmaceuticals is running and its propensity to invest more and deepen its relationship with Oracle , Microsoft , Docusign or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Valeant Pharmaceuticals revenues, which have grown to $8.43 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Valeant Pharmaceuticals intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Valeant Pharmaceuticals Tech Stack and Enterprise Applications
Valeant Pharmaceuticals ERP
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Oracle | Legacy | Oracle NetSuite ERP | ERP Financial | ERP | n/a | 2012 | 2012 |
In 2012, Valeant Pharmaceuticals implemented Oracle NetSuite ERP for ERP Financial. The deployment targeted consolidation of finance and accounting capabilities, centralizing corporate finance, controllership, accounts payable, and accounts receivable under a single cloud native financial platform. Oracle NetSuite ERP provided core financial process control including centralized ledger management, period close orchestration, and enterprise financial reporting to standardize close and reporting cycles.
Configuration work emphasized standard ERP Financial modules such as general ledger, accounts payable, accounts receivable, fixed assets, tax management, and consolidated financial reporting, with configuration of chart of accounts and accounting periods to align reporting across business units. Governance and process restructuring established centralized financial process ownership, standardized reconciliation and close procedures, and role based access controls to enforce segregation of duties and auditability. The implementation narrative centers on Oracle NetSuite ERP enabling Valeant Pharmaceuticals to standardize financial operations and create a unified set of financial records for ongoing corporate accounting workflows.
|
Valeant Pharmaceuticals Analytics and BI
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft BI (SSRS, SSAS, SSIS, SQL Server Reporting) | Analytics and BI | Analytics and BI | n/a | 2012 | 2018 |
In 2012, Valeant Pharmaceuticals implemented Microsoft BI (SSRS, SSAS, SSIS, SQL Server Reporting) to establish an Analytics and BI platform. The Microsoft BI stack was deployed on SQL Server with SSRS and SSIS running on Windows 2007 and Windows 2008 servers, providing a combined reporting, ETL and analytical services foundation.
The implementation emphasized SSRS 2008 report design and tuning, with responsibilities including designing, modifying, deploying and performance tuning of reports, installing custom fonts for report rendering, and troubleshooting report-related issues. ETL capabilities were realized through SSIS 2008 packages that loaded flat files and Excel sources, implemented slowly changing dimension type 2 logic, and automated file intake by downloading from FTP, unzipping, decrypting, loading into tables, and moving processed files to an archive folder.
Integrations focused on operational data flows and application database support, including phased promotion of SQL Server clients and artifacts from development to QA to production, configuration of scheduled jobs with database mail for failure notifications, and close collaboration with various business groups to assist database design and application integration. The Microsoft BI implementation also encompassed support to application developers, unit and integration testing, and remediation of UAT defects to stabilize reporting and ETL processes.
Governance and operational discipline were established through creation of workflow and process flow documentation, systematic testing for performance and data integrity, and daily incident resolution for user-reported issues. The engagement included installation and troubleshooting of SQL Server 2008, execution plan based SQL performance tuning, and ongoing job scheduling and monitoring to maintain the Microsoft BI reporting and ETL environment.
|
Valeant Pharmaceuticals Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2015 | 2015 |
In 2015, Valeant Pharmaceuticals implemented Microsoft 365. Microsoft 365 is used as a Collaboration platform and its presence is referenced on Valeant's public website.
The Microsoft 365 implementation aligns with standard Collaboration capabilities, including cloud hosted email, document management, team communication, and productivity applications, with typical functional components such as Exchange Online, SharePoint, OneDrive and Microsoft Teams evident from category-aligned configuration patterns. Deployment is consistent with a centralized cloud tenant model supporting enterprise collaboration for corporate and operational users, providing unified content storage, co authoring workflows, and consolidated communication channels. Governance and operational control are implied through tenant level administration, role based access controls, and content lifecycle practices common to Collaboration implementations, with the public site indicating Microsoft 365 is actively leveraged in Valeant's external presence.
|
Valeant Pharmaceuticals Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Digital Signing | Content Management |
|
2021 | 2021 |
|
Valeant Pharmaceuticals IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2015 | 2015 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2018 | 2018 |
|
Valeant Pharmaceuticals CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Identity and Access Management (IAM) | CyberSecurity |
|
2021 | 2021 |
|
|
|
|
|
Web Application Firewalls (WAF) | CyberSecurity |
|
2015 | 2015 |
|
IT Decision Makers and Key Stakeholders at Valeant Pharmaceuticals
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
|
|
BI & Analytics Application Lead | Manager | IT | |
|
|
|
Director of Financial Planning & Analysis, Consumer & Lens | Director | Finance | |
|
|
|
Senior IT Leader, IT Business Process | Manager | IT | |
|
|
|
Executive Vice President of Administration and Chief Human Capital Officer | CXO | Finance | |
|
|
|
Vice President Finance | VP | Finance | |
|
|
|
Vice President, Information Technology | VP | IT | |
|
Apps Being Evaluated by Valeant Pharmaceuticals Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Valeant Pharmaceuticals IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Valeant Pharmaceuticals digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Valeant Pharmaceuticals Technographics
Valeant Pharmaceuticals is a Manufacturing organization based in United States,
with around 19600 employees and annual revenues of $8.43 billion.
Valeant Pharmaceuticals operates a diverse technology stack with applications such as
Oracle NetSuite ERP, Microsoft BI (SSRS, SSAS, SSIS, SQL Server Reporting) and Microsoft 365,
covering areas like ERP Financial, Analytics and BI and Collaboration.
Valeant Pharmaceuticals has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Oracle and Microsoft.
Valeant Pharmaceuticals recently adopted applications including
DocuSign eSignature in 2021, Okta Identity Cloud in 2021 and Imperva CDN in 2018,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Valeant Pharmaceuticals’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Valeant Pharmaceuticals’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Valeant Pharmaceuticals technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.